Age-appropriate compliance and completion of up to five doses of pertussis vaccine in US children

Background: In the United States (US), diphtheria, tetanus, and acellular pertussis (DTaP) vaccination is recommended at 2, 4, and 6 months (doses 1–3), 15–18 months (dose 4), and 4–6 years (dose 5). The objective of this study (GSK study identifier: HO-14–14383) was to examine DTaP completion and c...

Descripción completa

Detalles Bibliográficos
Autores principales: Krishnarajah, Girishanthy, Malangone-Monaco, Elisabetta, Palmer, Liisa, Riehle, Ellen, Buck, Philip O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351022/
https://www.ncbi.nlm.nih.gov/pubmed/30024829
http://dx.doi.org/10.1080/21645515.2018.1502526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351022/
https://www.ncbi.nlm.nih.gov/pubmed/30024829
http://dx.doi.org/10.1080/21645515.2018.1502526

Ejemplares similares